The global microfluidics market size was estimated at USD 37.49 billion in 2024 and is anticipated to reach USD 73.85 billion by 2030, growing at a CAGR of 11.99% from 2025 to 2030. This strong growth trajectory is mainly attributed to the rising use of microfluidic devices across multiple scientific, clinical, and industrial domains, where they enable faster, more precise, and cost-effective analytical processes.

For example, in March 2025, a study conducted in the U.S. introduced an advanced microfluidics-based analytical technique designed to significantly enhance detection capability and overall accuracy. This innovation is expected to transform the landscape of chemical analysis, offering valuable benefits to sectors such as pharmaceutical development, environmental monitoring, and food safety assessment.

Moreover, microfluidic methods have already demonstrated high effectiveness in a wide range of applications, including measuring glucose levels, identifying infections, diagnosing dry eye disease, and evaluating vascular endothelial growth factor (VEGF) concentrations. The increasing deployment of such solutions across diagnostic and research activities is anticipated to further accelerate market expansion over the forecast period.

Key Market Trends & Insights:

• North America dominated the global microfluidics market, accounting for a 42.3% revenue share in 2024. This leadership position is supported by the region’s highly developed healthcare infrastructure, significant investments in research and development, and the strong presence of key industry players, particularly in the U.S. microfluidics market, which continues to benefit from technological advancements and a mature innovation ecosystem.

• In terms of materials, the polydimethylsiloxane (PDMS) segment recorded the highest revenue share of 36.60% in 2024, reflecting its widespread adoption due to advantages such as flexibility, biocompatibility, and ease of fabrication.

• From a technology perspective, the lab-on-a-chip segment held the largest market share at 37.49% in 2024, highlighting its growing importance in enabling miniaturized, high-throughput, and rapid diagnostic capabilities.

• By product type, the microfluidic components segment accounted for the largest revenue share in 2024 and is further expected to grow at the fastest CAGR throughout the forecast period. This trend underscores the increasing demand for essential components used in developing advanced microfluidic systems for research, diagnostics, and industrial applications.

Order a free sample PDF of the Microfluidics Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 37.49 Billion

• 2030 Projected Market Size: USD 73.85 Billion

• CAGR (2025-2030): 11.99%

• North America: Largest market in 2024

Key Companies & Market Share Insights:

The microfluidics market is shaped by the presence of several well-established players who maintain dominance through extensive product portfolios, strategic partnerships, and ongoing investments in research and development. Companies such as Danaher Corporation, Thermo Fisher Scientific, Agilent Technologies, and PerkinElmer continue to secure a significant share of the market owing to their strong global footprint and their ability to offer fully integrated solutions that support a wide range of applications, including diagnostics, drug discovery, and genomics.

Additionally, leading organizations—including Illumina, Inc., F. Hoffmann-La Roche Ltd, PerkinElmer, Agilent Technologies, Inc., and Thermo Fisher Scientific Inc.—remain at the forefront of the industry by leveraging their comprehensive product lines, well-established global distribution channels, and consistent R&D spending. These companies utilize their scale, diversified platforms, and strategic acquisitions to strengthen their competitive advantage across areas such as clinical diagnostics, genomics, and life sciences.

Furthermore, firms like Bio-Rad Laboratories, Inc., DH Life Sciences, LLC, and Abbott are actively broadening their market presence by concentrating on advanced microfluidic applications in molecular diagnostics, infectious disease testing, and personalized medicine. Through continuous innovation, collaborative initiatives, and expansion into new geographic regions, these companies play a key role in shaping the evolving competitive landscape of the microfluidics market.

Key Players

• Illumina, Inc.

• F. Hoffmann-La Roche Ltd

• Revitty

• Agilent Technologies, Inc.

• Bio-Rad Laboratories, Inc.

• Danaher

• Thermo Fisher Scientific, Inc.

• Abbott

• Standard Biotools

• thinXXS Microtechnology GmbH

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The microfluidics market is projected to expand significantly over the forecast period, driven by growing adoption of microfluidic technologies across research, diagnostics, and healthcare applications. Key trends supporting this growth include ongoing technological advancements, increased emphasis on point-of-care and lab-on-a-chip solutions, and continuous innovation from major industry players. Regional leadership is supported by strong research infrastructure and investment, while emerging markets are gaining traction due to rising healthcare and biotechnology demand.